Literature DB >> 23707042

Angina pectoris or myocardial infarctions, pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and paradoxical emboli.

Katherine Clark1, Reed E Pyeritz, Scott O Trerotola.   

Abstract

Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by vascular malformations, and many clinical complications are related to pulmonary arteriovenous malformations (PAVMs) because they provide direct right-to-left shunts. Paradoxical emboli through these shunts are a well-recognized cause of transient ischemic attack, stroke, and cerebral abscess. The aim of this study was to determine whether paradoxical emboli through PAVMs could manifest as cardiac ischemic events. The study included a single-center population of 98 patients with PAVMs. Eighty-four had undergone PAVM embolotherapy, and the remaining 14 patients had PAVMs too small to require embolization. Patients were interviewed by telephone and surveyed regarding their cardiopulmonary symptoms and histories of cardiac diagnoses. We found that 6 patients (which is 18% of patients with symptomatic PAVMs, n = 33, and 6% of the total cohort, n = 98) reported that they had experienced typical angina pectoris-like chest pain or had a myocardial infarction before PAVM embolotherapy. Five patients had had a cardiac catheterization, 4 had normal coronary arteries, and 1 had a single artery occlusion. In conclusion, we suggest that in patients with untreated PAVMs, cardiac ischemia can occur because of a paradoxical embolus through PAVMs to a coronary artery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23707042     DOI: 10.1016/j.amjcard.2013.04.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Intrapulmonary arteriovenous anastomoses in humans--response to exercise and the environment.

Authors:  Andrew T Lovering; Joseph W Duke; Jonathan E Elliott
Journal:  J Physiol       Date:  2015-01-07       Impact factor: 5.182

Review 2.  Contemporary Management of Pulmonary Arteriovenous Malformations.

Authors:  Nicholas Rauh; John Gurley; Sibu Saha
Journal:  Int J Angiol       Date:  2017-09-18

Review 3.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 4.  Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know.

Authors:  Claire S Kaufman; Jamie McDonald; Heather Balch; Kevin Whitehead
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

5.  Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.

Authors:  Weiyi Mu; Zachary A Cordner; Kevin Yuqi Wang; Kate Reed; Gina Robinson; Sally Mitchell; Doris Lin
Journal:  Genet Med       Date:  2017-10-19       Impact factor: 8.822

6.  Comorbidity among HHT patients and their controls in a 20 years follow-up period.

Authors:  Katrine Saldern Aagaard; Anette Drøhse Kjeldsen; Pernille Mathiesen Tørring; Anders Green
Journal:  Orphanet J Rare Dis       Date:  2018-12-14       Impact factor: 4.123

7.  Venous thrombosis via pulmonary arteriovenous malformation causing acute myocardial infarction in a relatively young female patient.

Authors:  China Goto; Shoichiro Yatsu; Hideki Wada; Satoru Suwa
Journal:  BMJ Case Rep       Date:  2022-02-28

8.  Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.

Authors:  Claire L Shovlin
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

9.  Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets.

Authors:  Claire L Shovlin; Basel Chamali; Vatshalan Santhirapala; John A Livesey; Gillian Angus; Richard Manning; Michael A Laffan; John Meek; Hannah C Tighe; James E Jackson
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

10.  Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report and Review of Literature.

Authors:  Suman Rao; Alisha Khan; Dana Aiello
Journal:  Cureus       Date:  2021-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.